Worku et al., 1994 - Google Patents
Modulation of Fc receptors for IgG on bovine polymorphonuclear neutrophils by interferon-γ through de novo RNA transcription and protein synthesisWorku et al., 1994
View PDF- Document ID
- 13838029584951504773
- Author
- Worku M
- Paape M
- Marquardt W
- Publication year
- Publication venue
- American journal of veterinary research
External Links
Snippet
Polymorphonuclear neutrophils (pmn) from 4 cows were preincubated (30 minutes, 37 C) in either actinomycin D (100 μg/ml) or puromycin (10 μg/ml), inhibitors of mRNA transcription and protein translation, or in medium 199. The pmn were incubated for a further 4.5 hours in …
- 210000003622 mature neutrocyte 0 title abstract description 23
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Weist et al. | Thymic regulatory T cell niche size is dictated by limiting IL-2 from antigen-bearing dendritic cells and feedback competition | |
Erokhina et al. | HLA‐DR+ NK cells are mostly characterized by less mature phenotype and high functional activity | |
Naik et al. | Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo | |
Kallies et al. | A role for Blimp1 in the transcriptional network controlling natural killer cell maturation | |
Ng et al. | Human CD4+ CD25+ cells: a naturally occurring population of regulatory T cells | |
Tani et al. | Enrichment for murine keratinocyte stem cells based on cell surface phenotype | |
Finke et al. | Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma | |
Wols et al. | The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity | |
Chiu et al. | Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines | |
Kinoshita et al. | Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34+ cord blood cells | |
Comeau et al. | CD123bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion? | |
Worku et al. | Modulation of Fc receptors for IgG on bovine polymorphonuclear neutrophils by interferon-γ through de novo RNA transcription and protein synthesis | |
Zarcone et al. | Ultrastructural analysis of human natural killer cell activation | |
Kouro et al. | Relationships between early B-and NK-lineage lymphocyte precursors in bone marrow | |
Sakabe et al. | Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens | |
Howe et al. | Role of interleukin 1 in early T cell development: Lyt-2-L3T4-thymocytes bind and respond in vitro to recombinant IL 1. | |
Sutherland et al. | Induction of the expression of HLA class I antigens on K562 by interferons and sodium butyrate | |
Williams et al. | Pluripotential hematopoietic stem cells in post-5-fluorouracil murine bone marrow express the Thy-1 antigen. | |
Funayama et al. | Parent cells for trophoblast hybridization II: AC1 and related trophoblast cell lines, a family of HGPRT-negative mutants of the choriocarcinoma cell line JEG-3 | |
Miller et al. | Limiting dilution analysis of T helper cell heterogeneity: a single class of T cell makes both IL 2 and IL 3. | |
Rothenberg et al. | Functional and phenotypic analysis of thymocytes in SCID mice. Evidence for functional response transitions before and after the SCID arrest point. | |
Zhang et al. | Antitumor effects of recombinant human prolactin in human adenocarcinoma-bearing SCID mice with human NK cell xenograft | |
Irani et al. | Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor. | |
Wiener et al. | Bone marrow‐derived mast cell differentiation is strongly reduced in histidine decarboxylase knockout, histamine‐free mice | |
Alshalani et al. | Cultured CD71+ erythroid cells modulate the host immune response |